SPQ Asia Capital’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

SPQ Asia Capital’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-21,824	Closed	-$2.47M	–	7
2017 Q2	$2.47M	Sell	21,824 -12,500	-36%	-$1.4M	4.76%	5
2017 Q1	$3.44M	Sell	34,324 -41,935	-55%	-$4.48M	7.65%	4
2016 Q4	$8.2M	Sell	76,259 -19,500	-20%	-$2.28M	12.3%	4
2016 Q3	$11.9M	Buy	95,759 +63,759	+199%	+$7.53M	28.32%	2
2016 Q2	$3.4M	Buy	+32,000	New	+$3.72M	2.63%	6

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIM

Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return

SPQ Asia Capital's CBPO Position: Q3 2017 in Review

SPQ Asia Capital sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2017, closing a stake of 21,824 shares — an estimated $2.47M sold.

SPQ Asia Capital first reported a position in CBPO in Q2 2016 and held it in 5 quarters. The position peaked at $11.9M in Q3 2016. 94 funds tracked by Wall St. Rank hold CBPO as of Q3 2017.

SPQ Asia Capital reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2017 after selling out during the quarter.
SPQ Asia Capital sold 21,824 China Biologic Products Holdings, Inc. shares in Q3 2017, an estimated $2.47M.
SPQ Asia Capital first reported a position in China Biologic Products Holdings, Inc. in Q2 2016 and held it in 5 quarters.
SPQ Asia Capital's China Biologic Products Holdings, Inc. position peaked at $11.9M in Q3 2016.
94 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2017.

Based on SPQ Asia Capital's 13F filing for Q3 2017, filed 14 Nov 2017.